Clinical Trial Update: Identification of Novel High Quality Methylated DNA Markers in Renal Tumors: Whole Methylome Discovery, Tissue Validation, and Feasibility Testing In Blood and Urine, The INQUIRE Study

View source ↗

Summary

A Mayo Clinic-led INQUIRE study is identifying novel high-quality methylated DNA markers for renal tumors. The project uses whole-methylome discovery, tissue va…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chromophobe Renal Cell Carcinoma
• Clear Cell Papillary Renal Tumor
• Clear Cell Renal Cell Carcinoma
• Papillary Renal Cell Carcinoma
• Renal Oncocytoma
• Urothelial Carcinoma

Snippet

Sponsor: Mayo Clinic | Conditions: Chromophobe Renal Cell Carcinoma, Clear Cell Papillary Renal Tumor | Status: ACTIVE_NOT_RECRUITING